These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33928167)

  • 1. Long-Term Immunological and Virological Outcomes in Children Receiving Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Sciences, Southern Ethiopia.
    Fenta DA; Wube TB; Nuru MM
    J Immunol Res; 2021; 2021():2498025. PubMed ID: 33928167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia: A cross-sectional study.
    Manaye GA; Abateneh DD; Asmare WN; Abebe M
    Medicine (Baltimore); 2021 Nov; 100(47):e27624. PubMed ID: 34964727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
    Hailu GG; Wasihun AG
    BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
    Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
    Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy.
    Melku M; Abebe G; Teketel A; Asrie F; Yalew A; Biadgo B; Kassa E; Damtie D; Anlay DZ
    Environ Health Prev Med; 2020 Aug; 25(1):43. PubMed ID: 32838734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
    Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
    Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia.
    Genet A; Mekonnen Z; Yizengaw E; Mekonnen D
    Afr Health Sci; 2021 Mar; 21(1):263-272. PubMed ID: 34394306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.
    Hailu GG; Hagos DG; Hagos AK; Wasihun AG; Dejene TA
    PLoS One; 2018; 13(5):e0196259. PubMed ID: 29715323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children.
    Singh R; Mukherjee A; Singla M; Das BK; Kabra SK; Lodha R
    Indian J Pediatr; 2017 Dec; 84(12):893-896. PubMed ID: 28875475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological Response of Hiv-Infected Children to Highly Active Antiretoviral Therapy at Gondar University Hospital, North-Western Ethiopia.
    Kokeb M; Degu G
    Ethiop J Health Sci; 2016 Jan; 26(1):25-30. PubMed ID: 26949313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
    Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
    PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
    He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
    PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia.
    Nega J; Taye S; Million Y; Rodrigo C; Eshetie S
    AIDS Res Ther; 2020 Jul; 17(1):39. PubMed ID: 32650796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
    Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE
    PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020/2021: A cross-sectional study.
    Kiros T; Taye A; Workineh L; Eyayu T; Damtie S; Hailemichael W; Tiruneh T
    Heliyon; 2022 Aug; 8(8):e10169. PubMed ID: 36033289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to viral load suppression and its associated factors in cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018.
    Ali JH; Yirtaw TG
    BMC Infect Dis; 2019 Dec; 19(1):1084. PubMed ID: 31881859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China.
    Zheng J; Zhao D
    BMC Res Notes; 2014 Jul; 7():419. PubMed ID: 24994004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.